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Abstract
Background: Anxiety levels in rats are correlated with interleukin-2 (IL-2) levels in the brain. The
aim of the present study was to investigate the effects of dioscorea (wild yam), a Chinese medicine,
on emotional behavior and IL-2 levels in the brain of ovariectomized (OVX) rats.
Methods: One month after ovariectomy, female Wistar rats were screened in the elevated plus-
maze (EPM) test to measure anxiety levels and divided into low anxiety (LA) and high anxiety (HA)
groups, which were then given dioscorea (250, 750, or 1500 mg/kg/day) by oral gavage for 27 days
and were tested in the EPM on day 23 of administration and in the forced swim test (FST) on days
24 and 25, then 3 days later, the brain was removed and IL-2 levels measured.
Results: Compared to sham-operated rats, anxiety behavior in the EPM was increased in half of
the OVX rats. After chronic dioscorea treatment, a decrease in anxiety and IL-2 levels was
observed in the HA OVX rats. Despair behavior in the FST was inhibited by the highest dosage of
dioscorea.
Conclusion: These results show that OVX-induced anxiety and changes in neuroimmunological
function in the cortex are reversed by dioscorea treatment. Furthermore, individual differences
need to be taken into account when psychoneuroimmunological issues are measured and the EPM
is a useful tool for determining anxiety levels when examining anxiety-related issues.
Background
Anxiety and depression are major symptoms in postmen-
opausal women. Decreased blood levels of sex hormones
are thought to be involved in these disorders [1], as post-
menopausal syndrome is significantly improved by hor-
mone replacement therapy, especially by a combined
estrogen-progesterone regimen [2]. Interleukin-2 (IL-2)
has recently been implicated as a modulator of neuronal
function [3]. Pawlak et al have reported that IL-2 mRNA
levels in the striatum and prefrontal cortex are relevant to
emotional behavior in the elevated plus-maze (EPM) test
[4,5] and that striatal microinjection of IL-2 causes an
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increase in the open arm time in the EPM test [6]. There is
evidence that IL-2 is involved in various emotional behav-
iors [7] and that systemic administration of IL-2 results in
anxiogenic activity [8]. In addition, IL-2/15Rβ knockout
mice exhibit decreased levels of anxiety behavior in the
EPM test compared to wild-type and heterozygote mice
[9].
Systemic administration of sex hormones, for example
estrogen and progesterone, modifies the affective behav-
ior of ovariectomized (OVX) Long-Evans rats, decreasing
anxiety, fear, and pain responses, through actions in cer-
tain brain areas [10]. Dioscorea (wild yam) has long been
used as a Chinese medicine for improving gastrointesti-
nal, sensory, memory, and sexual-related functions, and
also hot flushes and frequency of urination in postmeno-
pausal women. Animal studies have been used to evaluate
its effects on osteoporosis [11], diabetes [12], and hyperl-
ipidemia [13], which are very common in postmenopau-
sal women, but, as far as we are aware, there have been no
studies to date on the effect of dioscorea on behavior.
Diosgenin, the main steroidal saponin in dioscorea
[14,15], is used to manufacture steroidal hormones, such
as progesterone, estrogen, testosterone, and cortisone
[16,17], by in vitro chemical modification [18]; however,
a recent study on menopausal animals indicated that sex
hormone levels might not be affected by diosgenin treat-
ment [19]. Furthermore, dietary supplementation with
dioscorea does not affect dehydroepiandrosterone levels
in the blood [20]. It has therefore been hypothesized that
dioscorea, and/or diosgenin might not serve as a precur-
sor of sex hormones in vivo, but affect menopausal symp-
toms by another mechanisms.
Recent studies indicated that dioscorea has an anti-
inflammatory action both in vivo [21] and in vitro, decreas-
ing the production of cytokines [22]. However, little is
known about the role of IL-2 in menopausal syndrome.
As IL-2 in the brain is involved in emotional behavior and
its effects are area-dependent [3,23], it was of interest to
examine the effects of dioscorea on IL-2 levels in the brain
of menopausal animals.
OVX rats were used as a menopausal animal model
because the changes in biochemical and physiological
function seen in these animals are comparable with those
in menopausal women [24], i.e., decreased levels of pro-
gesterone and estrogen [25], an increased risk of cardio-
vascular disease [26], and an enhanced rate of bone loss
[27,28], as well as an increased anxiety level [29]. The
time spent in the open arm during the EPM test is used to
evaluate unconditioned avoidance behavior as a measure
of anxiety [30,31], while immobility, a despair behavior,
in the forced swim test (FST) is used to measure learned
helplessness as a model of depression [32]. As far as we are
aware, there are no published studies of the effect of dio-
scorea on anxiety and depression caused by OVX. In deter-
mining whether the responses of emotional behavior and
IL-2 function in OVX rats to dioscorea treatment differed
between low anxiety (LA) and high anxiety (HA) rats, we
screened a group of OVX rats using the EPM test and
divided them into LA and HA rats, then subjected both
groups to chronic dioscorea treatment and measured their
behavioral responses in the EPM and FST. The effects of
dioscorea on IL-2 levels in brain tissue were also examined
using an enzyme linked immunosorbent assay (ELISA).
Methods
Animals
Female Wistar rats (261 ± 4 g; n = 99; National Laboratory
Animal Center, ROC) were used and housed in groups of
five in acrylic cages (35 × 56 × 19 cm) in an animal room
with a 12 h light/dark cycle (lights on at 07:00) with food
and water provided ad libitum. Each animal was handled
for 15 min/day on two consecutive days prior to the exper-
iment. All experimental procedures were performed
according to the NIH Guide for the Care and Use of Lab-
oratory Animals and were approved by the Animal Care
Committee of Chung Shan Medical University.
General procedure
On day 28 after ovariectomy, a 10 min open field test was
performed, followed by a 5 min EPM test on day 29. The
animals were then divided into LA and HA rats and were
given dioscorea (250, 750, or 1500 mg/kg/day) or vehicle
(distilled water) by oral gavage for 27 days. On day 23 of
dioscorea treatment, the EPM test was performed, fol-
lowed by a FST on days 24 and 25 (see details of the
schedule in Table 1). All behavioral tests were begun 2 h
after start of lights-on and were performed before the dio-
scorea treatment for that day. The animals were weighed
in the animal room, placed individually in a clean cage
(25 × 41 × 19 cm), and transported to a dim observation
room (28 lux) for behavioral testing. The test equipment
was thoroughly cleaned using 20% alcohol followed by
thorough drying before each rat was tested. The behavio-
ral parameters of the open field test were analyzed using
an automated computer program, while behavior in the
EPM test and the FST was scored from videotapes.
Ovariectomy
An aseptic surgical procedure was employed for all ani-
mals. The rats were anesthetized using ketamine (100 mg/
kg, IM), then the dorsal part of the lumbar region was
shaved, and the site cleaned with 75% ethanol followed
by thorough scrubbing with 10% povidone iodine. A 2 cm
incision was made in the skin through the musculature
and peritoneum and the ovaries were retracted and
removed. The wound was then closed using a 4-O sterile
suture. Immediately after surgery, each rat was injectedAnnals of General Psychiatry 2007, 6:21 http://www.annals-general-psychiatry.com/content/6/1/21
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with penicillin-G procaine (0.2 ml, 20000 IU, IM), and
the wound again cleaned with povidone iodine to reduce
the chance of post-operative infection. The sham-oper-
ated group underwent the same surgical procedure except
for the removal of the ovaries. After OVX, the rats were
housed individually in plastic cages (25 × 41 × 19 cm) for
about 10 days for recovery, then re-grouped in their home
cages.
Behavioral tests
Open field
The open field consisted of an acrylic box (40 × 40 × 40
cm). The movement distance of the rat during a 10 min
observation was monitored using an automated activity
monitoring system (Digiscan-16 Animal Activity Monitor
System; model RXYZCM, Omnitech Electronics Colum-
bus, OH, USA) [33].
EPM test
The EPM apparatus was made of plastic and consisted of
two opposed open arms (50 × 10 cm), two opposed
enclosed arms with no roof (50 × 10 × 40 cm), and an
open square (10 × 10 cm) in the center, and was located
50 cm above the floor. Behavior in the EPM was observed
for 5 min as described previously [34]. The following
measures were analyzed from videotapes: (1) arm time:
the time spent in open or enclosed arms, (2) arm entries:
the number of entries into open or enclosed arms, and (3)
arm activity: the number of time an animal crossed a vir-
tual line that divided an arm into a proximal and a distal
half. An entry into any of the compartments was defined
as all four paws being placed in the compartment. The
EPM test was performed twice in this study: once 4 weeks
after ovariectomy and once on day 23 of dioscorea treat-
ment. The open arm time in the first EPM test was used to
screen individual anxiety levels and to establish high and
low open arm responder groups of the same size.
Forced swim test
This test was carried out in a clear glass tank (25 × 25 × 60
cm) containing 39 cm of clean water at 26°C. The appara-
tus was cleaned thoroughly and the water changed
between tests on different rats. A swimming test was per-
formed on two consecutive days (15 min on day 1 and 5
min on day 2) and videotaped as described previously
[35]. Immobility was measured from the videotapes and
was defined as when the rats remained motionless or
floating (including small limb movements to keep their
heads above the water) [36]. To determine the effect of the
FST on IL-2 levels, one-third of the rats were randomly
assigned not to be subjected to the FST.
Measurement of IL-2 levels
Three days after the FST, the rats were killed by exposure
to CO2 and their brains immediately removed. The pre-
frontal cortex (the rostral part of the cortex, not including
the forceps minor corpus callosum, about 12 mm anterior
of the coronal plane passing through the interaural line,
according to the atlas of Paxinos and Watson [37]) and
the rest of the cerebral cortex (termed the "cerebral cortex"
in this study) were dissected out on an ice-bath plate. The
protein in the tissue was extracted by homogenizing the
tissue in ice-cold lysis buffer (50 mM Tris-HCl, pH7.6,
0.5% NP-40, 150 mM NaCl, 1 mM EDTA, 10% glycerol
containing protease inhibitors (1 µg/ml of aprotinin, 0.5
µg/ml of leupeptin, and 100 µg/ml of 4-(2-aminoethyl)
benzenesulfonyl fluoride)). The homogenate was centri-
fuged at 2900 g for 15 min at 4°C (Hermle Z323 K centri-
fuge, Gosheimerstr, Germany), the supernatant re-
centrifuged under the same conditions, and the final
supernatant taken and its protein concentration measured
using a Bio-Rad protein assay kit (Bio-Rad laboratories,
CA, USA). A sample containing about 30–40 µg of protein
was used to measure IL-2 levels using an ELISA kit with
monoclonal anti-mouse IL-2 antibody (CytoSets™, Bio-
Sourse, CA, USA) according to the manufacturer's instruc-
tions. The color reaction was stopped after 30 min by
addition of 2N H2SO4 and the optical density read at 450
nm within 30 min on an ELISA reader. The IL-2 levels
were then calculated from a standard curve.
Dioscorea
Dioscorea (D. L. alata. Var. purpurea (Roxb.) M. Pouch;
Tainung No. 1 Shan-Yao) was purchased from Ming-Jean
town, Nan Tao County, Taiwan. The yam tubers were
cleaned, peeled, sliced into 1 cm wide slices, and boiled
for 30 min to inhibit the browning reaction. Put the
cooked sample, thereafter, to the moisture to around
10%, milled to a flour that passed through a 60 mesh
sieve, and stored at -25°C until use. The dose of dioscorea
Table 1: Schedule of treatment and behavioral tests in the present study
Day 1 2–27 28 29 30–50 51 52 53 54–55 56
Treatment Ovariectomy Dio Dio Dio Dio Dio Dio Killed
Test Open field EPM EPM FST day 1 FST day 2
(10 min) (5 min) (5 min) (15 min) (5 min)
Animals underwent ovariectomy on day 1 and were killed on day 56. Dioscorea (Dio) was given daily by oral gavage from day 29 to day 55. EPM, 
elevated plus-maze test; FST, forced swim test.Annals of General Psychiatry 2007, 6:21 http://www.annals-general-psychiatry.com/content/6/1/21
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was freshly prepared before use by adding double distilled
water and mixing.
Data analysis
As in our previous study [34], the OVX rats were ranked
using the open arm time in the first EPM test, then
assigned, using the median value, to two subgroups with
high anxiety levels (34 animals with a shorter open arm
time; HA rats) or low anxiety levels (34 animals with a
longer open arm time; LA rats). These groups were used to
examine the effect of dioscorea on behavior and IL-2 lev-
els. Statistical testing was performed to compare within or
between groups using t-tests for paired or unpaired data.
Analysis of the effects of dioscorea was carried out by one-
way analysis of variance (ANOVA), followed by a least-
significant difference (LSD) post hoc test. All results are
expressed as the mean ± SEM. The level of significance was
defined as p < 0.05.
Results
Behavior after ovariectomy
Four weeks after ovariectomy, the open arm time of OVX
rats in the EPM test was shorter than that of sham-oper-
ated rats (df = 97, t  = 2.576, p = 0.012), whereas the
enclosed arm time was longer in OVX rats than sham-
operated rats (df = 97, t = 2.572, p = 0.012). Open arm
activity, closed arm activity, and total arm activity were
not different between OVX and sham-operated rats (Table
2). Furthermore, the movement distance in the open field
test was not different between OVX and sham-operated
rats (2644 ± 129 cm vs 2903 ± 132 cm).
The OVX rats were divided into HA and LA subgroups
based on the median value of the OVX rats for the open
arm time in the first EPM test [34]. These subgroups (each
of 34 rats) had the following profiles: The open arm time
and open arm activity were significantly lower in HA rats
than in LA rats (both p values < 0.001), while the enclosed
arm time and enclosed arm activity were significantly
higher than in LA rats (both p values < 0.05). Total arm
activity was not different between HA and LA rats. Inter-
estingly, all of these values in LA rats were similar to those
in sham-operated rats (Table 2).
Behavior after dioscorea treatment
Dioscorea did not affect the behavior of sham-operated
rats in the EPM test (Table 3), but significantly changed
the EPM behavior of OVX rats (Table 4). In HA OVX rats,
the open arm time and open arm activity were increased
(both p values < 0.01) and the enclosed arm time and
enclosed arm activity decreased (both p values < 0.05)
after treatment with 750 mg/kg/day compared to before
treatment. Similar effects were observed at the dosage of
1500 mg/kg/day (p value < 0.05), while the dosage of 250
mg/kg/day had no effect. Interestingly, dioscorea at 250
mg/kg/day, but not at the other two dosages, significantly
decreased the open arm time and open arm activity of
OVX LA rats (both p values < 0.05). None of the dosages
of dioscorea affected the total arm activity in the EPM test.
Forced swim test
The immobility time during the first 5 min of the first FST
in OVX rats treated with vehicle (distilled water) or 750
mg/kg dioscorea was significantly higher than that in
sham-operated rats treated with the same dosage (both p
values < 0.01, t-test). Learned helplessness was observed
in all groups; the immobility time in the second FST ses-
sion was significantly longer than that on the previous day
(all pvalues < 0.05), except in the OVX group receiving
1500 mg/kg/day of dioscorea (Figure 1). Forced swim-
ming behavior was not compared between HA and LA rats
because there was no correlation between the immobility
time in the first FST session and anxiety levels shown by
the open arm time in the first EPM test. In addition, the
number of animals in each group was too small to reach
statistical power when the rats were divided into HA and
LA subgroups (a third of the rats were not used in the FST).
IL-2 levels
IL-2 levels in the brain areas analyzed were not influenced
by the animals being subjected to the FST (data not
shown), so the combined data for these two groups were
Table 2: Behavior in the EPM test at 4 weeks after ovariectomy
OVX
Sham (n = 31) (n = 68) LA subgroup (n = 34) HA subgroup (n = 34)
OAT 50.6 ± 7.4 30.8 ± 4.0 # 56.3 ± 4.6 5.3 ± 1.6 ##**
CAT 215.7 ± 9.5 241.1 ± 5.1 # 211.2 ± 5.7 270.9 ± 4.2 ##**
OAA 6.0 ± 1.1 4.1 ± 0.7 7.6 ± 1.0 0.7 ± 0.3 ##**
CAA 21.2 ± 1.8 24.3 ± 1.1 21.6 ± 1.3 26.9 ± 1.6 #*
TAA 27.2 ± 2.1 28.4 ± 1.2 29.2 ± 1.8 27.6 ± 1.7
LA, low anxiety; HA, high anxiety; OAT, open arm time; CAT, enclosed arm time; OAA, open arm activity; CAA, enclosed arm activity; TAA, total 
arm activity. #, p < 0.05; ##, p < 0.001, compared to the sham-operated group; *, p < 0.05; **, p < 0.001, compared to the LA subgroup. The data 
are expressed as the mean ± SEM.Annals of General Psychiatry 2007, 6:21 http://www.annals-general-psychiatry.com/content/6/1/21
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used. As shown in Table 5, none of the dosages of diosco-
rea used affected IL-2 levels in the prefrontal cortex and
cerebral cortex in sham-operated rats. IL-2 levels in the
prefrontal cortex of vehicle-treated OVX LA rats were
lower than those in vehicle-treated sham-operated rats (p
< 0.05); however, this was reversed by treatment with dio-
scorea at the dosage of 250 mg/kg/day (p < 0.05), but not
the other dosages. Levels in the cerebral cortex were unaf-
fected by any dosage. In addition, all three dosages used
in this study (250, 750, and 1500 mg/kg/day) signifi-
cantly decreased IL-2 levels in the cerebral cortex of OVX
HA rats compared to vehicle-treated OVX HA rats (p-val-
ues < 0.05), but had no effect on levels in the prefrontal
cortex (Table 5).
Discussion
The present study showed that, at 1 month after ovariec-
tomy, anxiety levels were highly increased in half of the
rats. Chronic administration of dioscorea at dosages of
750 and 1500 mg/kg/day, but not at 250 mg/kg/day, had
an anxiolytic activity in HA OVX rats, increasing the open
arm time and decreasing the enclosed arm time in the
EPM test. However, a lower dosage of dioscorea, 250 mg/
kg/day, (but not the dosages of 750 and 1500) increased
anxiety levels in LA OVX rats. These behavioral data are
compatible with the data for IL-2 levels, which showed
that IL-2 levels in the cerebral cortex of HA OVX rats were
significantly decreased by all three dosages of dioscorea,
while IL-2 levels in the prefrontal cortex of LA OVX rats
were increased by dioscorea at 250 mg/kg/day. These
effects of dioscorea were not due to non-specific effects on
activity, as no effect was seen on total arm activity in the
EPM test. In addition, learned helplessness in the FST was
inhibited by dioscorea at 1500 mg/kg/day. The present
data suggest that IL-2 in the brain could play a role in
postmenopausal anxiety and could be involved in the
mechanisms by which dioscorea decreases anxiety levels
in HA OVX rats.
OVX rats are used as a menopausal animal model, as the
changes in biochemical and physiological function are
comparable with those seen in menopausal women [24],
Table 4: Effect of chronic dioscorea administration on the behavior of OVX rats in the EPM test
LA rats HA rats
0 mg/kg/day 
(n = 8)
250 mg/kg/day 
(n = 10)
750 mg/kg/day 
(n = 9)
1 500 mg/kg/day 
(n = 7)
0 mg/kg/day 
(n = 7)
250 mg/kg/day 
(n = 8)
750 mg/kg/day 
(n = 9)
1 500 mg/kg/day 
(n = 10)
OAT Before 59.3 ± 8.9 50.6 ± 6.5 57.5 ± 9.6 59.6 ± 14.5 5.1 ± 3.6 6.0 ± 3.3 6.5 ± 3.4 3.9 ± 2.7
After 32.3 ± 11.4 23.2 ± 7.1 ** 49.6 ± 9.5 37.6 ± 14.2 10.8 ± 5.8 17.2 ± 6.9 33.5 ± 8.4 ** 21.3 ± 7.2 *
CAT Before 205.5 ± 9.4 220.8 ± 8.8 209.3 ± 12.5 206.6 ± 16.8 277.0 ± 11.8 269.2 ± 7.5 261.8 ± 9.6 276.3 ± 5.3
After 228.3 ± 19.4 247.0 ± 14.6 211.1 ± 15.6 224.2 ± 22.4 264.2 ± 10.7 264.9 ± 10.4 239.3 ± 13.9 * 239.6 ± 12.8 *
OAA Before 8.0 ± 0.8 5.2 ± 0.9 9.7 ± 2.8 8.0 ± 2.8 0.6 ± 0.6 0.8 ± 0.5 0.9 ± 0.9 0.4 ± 0.3
After 6.3 ± 1.9 2.8 ± 0.9 * 7.6 ± 1.9 5.4 ± 2.3 1.1 ± 0.9 2.5 ± 1.2 3.9 ± 1.3 ** 1.8 ± 0.7
CAA Before 21.8 ± 3.4 19.5 ± 1.3 24.0 ± 2.8 21.3 ± 3.4 27.1 ± 3.3 23.1 ± 3.4 28.4 ± 3.4 28.5 ± 3.1
After 20.5 ± 3.5 22.1 ± 3.0 21.3 ± 2.4 21.1 ± 3.5 20.6 ± 1.9 18.1 ± 2.8 19.9 ± 2.6 * 24.9 ± 2.8
TAA Before 29.8 ± 3.5 24.7 ± 1.7 33.7 ± 4.2 29.3 ± 5.3 27.7 ± 3.5 23.9 ± 3.5 29.3 ± 3.5 28.9 ± 3.0
After 26.8 ± 4.0 24.9 ± 3.1 28.9 ± 3.0 26.6 ± 3.5 21.7 ± 2.0 20.6 ± 2.8 23.8 ± 2.5 26.7 ± 2.7
LA, low anxiety; HA, high anxiety; OAT, open arm time; CAT, enclosed arm time; OAA, open arm activity; CAA, enclosed arm activity; TAA, total 
arm activity. The data are expressed as the mean ± SEM. "Before" and "after" are the results for the EPM test before, and on day 23 of, dioscorea 
treatment. *, p < 0.05; **, p < 0.01, paired t-test, compared to the data before dioscorea treatment.
Table 3: Effect of chronic dioscorea administration on the behavior of sham-operated rats in the EPM test
0 mg/kg/day (n = 11) 250 mg/kg/day (n = 11) 750 mg/kg/day (n = 9)
OAT Before 40.4 ± 11.5 57.7 ± 11.9 54.4 ± 16.3
After 41.5 ± 10.2 58.7 ± 13.0 35.7 ± 9.9
CAT Before 228.9 ± 16.7 206.0 ± 16.3 211.4 ± 17.4
After 221.7 ± 15.0 174.3 ± 25.5 225.8 ± 13.1
OAA Before 3.9 ± 1.3 7.7 ± 1.7 6.6 ± 2.5
After 6.2 ± 1.5 8.2 ± 1.6 6.0 ± 2.1
CAA Before 20.5 ± 2.6 22.3 ± 3.9 20.7 ± 3.0
After 22.6 ± 2.4 18.4 ± 2.6 23.6 ± 1.6
TAA Before 24.4 ± 3.4 30.0 ± 3.6 27.2 ± 4.0
After 28.7 ± 2.6 26.6 ± 3.1 29.6 ± 2.5
OAT, open arm time; CAT, enclosed arm time; OAA, open arm activity; CAA, enclosed arm activity; TAA, total arm activity. The data are 
expressed as the mean ± SEM. "Before" and "after" are the results for the EPM test before, and on day 23 of, dioscorea treatment.Annals of General Psychiatry 2007, 6:21 http://www.annals-general-psychiatry.com/content/6/1/21
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i.e. decreased levels of progesterone and estrogen [25],
increased risk of cardiovascular disease [26], and
enhanced rate of bone loss [27,28]. Although anxiety and
depression are very common in menopausal women and
elevation of anxiety levels has been reported in Long-
Evans [38] and Wistar rats [29] after ovariectomy, the
present study indicated that, compared to the sham-oper-
ated group, only half of OVX rats fell into the "high anxi-
ety" group. This finding is compatible with results from
clinical research, as anxiety is not seen in all postmeno-
pausal women [39].
Dioscorea has long been used as a Chinese medicine for
improving gastrointestinal, sensory, memory, and sexual-
related functions. Several lines of evidence have demon-
strated that it is effective in the treatment of osteoporosis
[11], diabetes [12], and hyperlipidemia [13]; but there
have not been any reports of its effect on behavior. Our
data showed that oral administration of dioscorea
decreased anxiety and depressive behavior in menopausal
animals.
The sex hormone system could be involved in the behav-
ioral effects of dioscorea. Decreased blood levels of sex
hormone are thought to be involved in disorders after
menopause [1], as postmenopausal syndrome is signifi-
cantly improved by hormone replacement therapy, espe-
cially by a combined estrogen-progesterone regimen [2].
Diosgenin, the main steroidal saponin in dioscorea
[14,15], is used to manufacture steroidal hormones, such
as progesterone, estrogen, testosterone, and cortisone
[16,17]. There are no reports on the exact mechanisms by
which diosgenin is converted to other hormones in vivo,
but a previous study showed that hypertrophy of the adre-
nal cortex in OVX animals was reversed towards control
values after continuous supplementation with diosgenin
[19]. Furthermore, the consumption of wild Mexican yam
products containing diosgenin increases progesterone
activity in the saliva [40], suggesting that the steroidal hor-
mone system is affected.
IL-2 has recently been implicated as a modulator of neu-
ronal function and emotional behavior [3]. IL-2 can influ-
ence neuronal activity [7], and an anxiogenic effect has
been observed after the systemic administration of IL-2
[8]. The EPM is a widely used behavioral paradigm in the
field of experimental anxiety research [41], and the values
in this test are reported to correlate with anxiety-like and
fear-motivated avoidance behavior [31,42]. During a typ-
ical EPM test, animals spend most of their time in the
enclosed arms, rather than the open arms of the plus-
maze, showing defensive behavior. Pawlak et al [6]
reported that striatal microinjection of IL-2 affects emo-
tional behavior in the EPM test. In addition, IL-2/15Rβ
knockout mice exhibit decreased levels of anxiety-like
behaviour in the EPM test compared to wild-type and het-
Table 5: Effect of chronic dioscorea administration on IL-2 levels in the brain
OVX
Sham LA rats HA rats
0 mg/kg 
(n = 10)
250 mg/kg 
(n = 11)
750 mg/kg 
(n = 9)
0 mg/kg 
(n = 8)
250 mg/kg 
(n = 10)
750 mg/kg 
(n = 9)
1 500 mg/
kg (n = 7)
0 mg/kg 
(n = 7)
250 mg/kg 
(n = 7–8)
750 mg/kg 
(n = 9)
1 500 mg/
kg (n = 10)
Prefrontal cortex 2.4 ± 0.2 2.7 ± 0.3 2.4 ± 0.2 1.7 ± 0.2# 2.5 ± 0.1* 2.2 ± 0.3 1.8 ± 0.3 1.9 ± 0.2 2.1 ± 0.2 2.3 ± 0.3 2.2 ± 0.2
Cerebral cortex 1.9 ± 0.4 1.8 ± 0.3 1.3 ± 0.2 1.6 ± 0.2 1.8 ± 0.3 2.1 ± 0.4 1.7 ± 0.2 2.7 ± 0.6 1.5 ± 0.2* 1.5 ± 0.2** 1.4 ± 0.2**
LA, low anxiety; HA, high anxiety. #, p < 0.05, compared to the untreated sham-operated rats; *, p < 0.05; **, p < 0.01, compared to the untreated 
rats in the same anxiety category. The data are expressed as the mean ± SEM. The units are pg/µg protein.
Effects of chronic administration of dioscorea on immobility  in the forced swim test Figure 1
Effects of chronic administration of dioscorea on 
immobility in the forced swim test. Dioscorea (0, 250, 
750, or 1 500 mg/kg/day) was given by oral gavage for 27 days 
and the rats were tested on days 24 and 25. The number of 
rats in each group is shown in parentheses below each group. 
* p < 0.05, ** p < 0.01, *** p < 0.001, compared to the data 
for the first session, paired t-test. ## p < 0.01, compared to 
sham-operated rats treated with the same dosage. The data 
are expressed as the mean ± SEM.
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erozygote mice [9]. Chronic administration of IL-2 causes
a reduction in exploration and approach to a novel stim-
ulus [43], indicating a correlation between IL-2 and defen-
sive behavior. In the present study, decreased avoidance of
the open arm of the EPM correlated with lowered levels of
IL-2 in the cerebral cortex in HA OVX rats treated with dio-
scorea. Furthermore, a decrease in open arm time and an
increase in IL-2 level in the prefrontal cortex of LA OVX
rats were seen after treatment with dioscorea at 250 mg/
kg/day.
A previous study indicated that intracerebroventricular
administration of IL-1beta and tumor necrosis factor-α
provokes an anxiogenic response in the EPM test without
affecting neurotransmitter concentrations in the amy-
gdala [23]. However, the dopaminergic system in the
striatum is reported to be sensitive to modulation by IL-2
[3]. The present study showed that the anxiogenic effects
of 250mg/kg/day of dioscorea in LA OVX rats were accom-
panied by an increase in IL-2 levels in the prefrontal cor-
tex, while anxiolytic activity in HA OVX rats was
accompanied by a decrease in IL-2 levels in the cerebral
cortex. These data support the view that the function of
cytokines is area-specific [3,5]. As the amygdala is corre-
lated with the pathophysiology of anxiety, the function of
IL-2 in this area deserves further study.
The immobility time in the first FST session was higher in
OVX rats than in sham-operated rats, suggesting that the
basal level of despair behavior was higher in OVX rats. In
addition, only the highest dosage of dioscorea blocked
learned helplessness, while the anxiolytic effects were
observed at lower dosages, showing that the biological
basis of anxiety and depression is not identical [34,35].
Furthermore, the effects of dioscorea on behavior and IL-
2 levels were dependent on the anxiety levels of the OVX
rats and had task-dependent behavioral consequences,
indicating that cytokine responses to treatment might be
involved in the individual differences in anxiety levels.
Conclusion
Compared to the sham-operated group, anxiety levels
were higher in 50% of the OVX rats. The anxiolytic activity
of chronic dioscorea treatment correlated with a decrease
in IL-2 levels in the cerebral cortex of HA OVX rats. In con-
trast, the anxiogenic effect of dioscorea in LA OVX rats was
accompanied by an increase in IL-2 levels in the prefrontal
cortex. In addition, learned helplessness in the FST was
decreased by the highest dosage of dioscorea. The present
results provide a new insight into the pathophysiological
role of IL-2 in postmenopausal anxiety. IL-2 could be
involved in the mechanisms underlying the behavioral
effects of dioscorea.
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